83 related articles for article (PubMed ID: 28745988)
21. ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules.
Solimena M; Dirkx R; Hermel JM; Pleasic-Williams S; Shapiro JA; Caron L; Rabin DU
EMBO J; 1996 May; 15(9):2102-14. PubMed ID: 8641276
[TBL] [Abstract][Full Text] [Related]
22. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen.
Pietropaolo M; Castaño L; Babu S; Buelow R; Kuo YL; Martin S; Martin A; Powers AC; Prochazka M; Naggert J
J Clin Invest; 1993 Jul; 92(1):359-71. PubMed ID: 8326004
[TBL] [Abstract][Full Text] [Related]
23. Plant-based vaccines for oral delivery of type 1 diabetes-related autoantigens: Evaluating oral tolerance mechanisms and disease prevention in NOD mice.
Posgai AL; Wasserfall CH; Kwon KC; Daniell H; Schatz DA; Atkinson MA
Sci Rep; 2017 Feb; 7():42372. PubMed ID: 28205558
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterial Hsp65 potentially cross-reacts with autoantibodies of diabetes sera and also induces (in vitro) cytokine responses relevant to diabetes mellitus.
Rani PS; Babajan B; Tulsian NK; Begum M; Kumar A; Ahmed N
Mol Biosyst; 2013 Nov; 9(11):2932-41. PubMed ID: 24056978
[TBL] [Abstract][Full Text] [Related]
25. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
[TBL] [Abstract][Full Text] [Related]
26. T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Lohmann T; Halder T; Engler J; Morgenthaler NG; Khoo-Morgenthaler UY; Schröder S; Seissler J; Scherbaum WA; Kalbacher H
Exp Clin Endocrinol Diabetes; 1999; 107(3):166-71. PubMed ID: 10376440
[TBL] [Abstract][Full Text] [Related]
27. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes.
Rondas D; Crèvecoeur I; D'Hertog W; Ferreira GB; Staes A; Garg AD; Eizirik DL; Agostinis P; Gevaert K; Overbergh L; Mathieu C
Diabetes; 2015 Feb; 64(2):573-86. PubMed ID: 25204978
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.
Kawasaki E; Hutton JC; Eisenbarth GS
Biochem Biophys Res Commun; 1996 Oct; 227(2):440-7. PubMed ID: 8878534
[TBL] [Abstract][Full Text] [Related]
29. Changing faces, unmasking the beta-cell: post-translational modification of antigens in type 1 diabetes.
van Lummel M; Zaldumbide A; Roep BO
Curr Opin Endocrinol Diabetes Obes; 2013 Aug; 20(4):299-306. PubMed ID: 23770733
[TBL] [Abstract][Full Text] [Related]
30. [Glutamate decarboxylase (GAD)--an autoantigen in insulin-dependent diabetes mellitus (IDDM)].
Tursky T; Bandzuchova E
Bratisl Lek Listy; 1999 Feb; 100(2):85-8. PubMed ID: 10493003
[TBL] [Abstract][Full Text] [Related]
31. [A new apparatus for intralymphatic injection with the elastic method].
Szikszai T; Georgescu T
Chirurgia (1951); 1974 Apr; 23(4):371-5. PubMed ID: 4847751
[No Abstract] [Full Text] [Related]
32. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.
Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P
Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648
[TBL] [Abstract][Full Text] [Related]
33. Tolerance to islet autoantigens in type 1 diabetes.
Bach JF; Chatenoud L
Annu Rev Immunol; 2001; 19():131-61. PubMed ID: 11244033
[TBL] [Abstract][Full Text] [Related]
34. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents.
Honeyman MC; Stone NL; Harrison LC
Mol Med; 1998 Apr; 4(4):231-9. PubMed ID: 9606176
[TBL] [Abstract][Full Text] [Related]
35. Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65).
Nepom GT; Lippolis JD; White FM; Masewicz S; Marto JA; Herman A; Luckey CJ; Falk B; Shabanowitz J; Hunt DF; Engelhard VH; Nepom BS
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1763-8. PubMed ID: 11172025
[TBL] [Abstract][Full Text] [Related]
36. Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes.
Castaño L; Russo E; Zhou L; Lipes MA; Eisenbarth GS
J Clin Endocrinol Metab; 1991 Dec; 73(6):1197-201. PubMed ID: 1955501
[TBL] [Abstract][Full Text] [Related]
37. On the pathogenicity of autoantigen-specific T-cell receptors.
Burton AR; Vincent E; Arnold PY; Lennon GP; Smeltzer M; Li CS; Haskins K; Hutton J; Tisch RM; Sercarz EE; Santamaria P; Workman CJ; Vignali DA
Diabetes; 2008 May; 57(5):1321-30. PubMed ID: 18299317
[TBL] [Abstract][Full Text] [Related]
38. Multiple target antigens in pre-type I diabetes: implications for prediction.
Ziegler R; Eisenbarth GS
Horm Res; 1990; 33(2-4):144-50; discussion 150-1. PubMed ID: 2210619
[TBL] [Abstract][Full Text] [Related]
39. [FIRST RESULTS OF INTRALYMPHATIC RADIOTHERAPY IN MALIGNANT LYMPHOGRANULOMA].
DIPIETRO S; USLENGHI C
Tumori; 1965; 51():113-29. PubMed ID: 14337657
[No Abstract] [Full Text] [Related]
40. GAD antigen and its significance in type I diabetes.
Hawa MI; Leslie RD
J Endocrinol Invest; 2002; 25(7):576. PubMed ID: 12150328
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
